News

Latest News
Jun 14, 2019

Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced the expansion of the...

May 20, 2019

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today announced the presentation of data from its pivotal Phase 3 efficacy studies and a...

May 18, 2019

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ (fluticasone propionate and salmeterol inhalation powder, USP)...

May 17, 2019

Mylan N.V. (NASDAQ: MYL) yesterday presented at the Bank of America Merrill Lynch Healthcare Conference, where the company announced that it will host an Investor Day on July 31, 2019 in New York...

May 15, 2019

Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that final data from the HERITAGE study will be presented at the 2019 American Society of Clinical Oncology...

View More

Search News Releases
Contact Mylan Communications

Global Communications 
724.514.1968
communications@mylan.com

Stay Connected

Mylan: Seeing is Believing

You are leaving Mylan.com

By clicking Continue below you are leaving Mylan.com and going to a third-party site.